Nick Roesen

Gilde Investment Management BV is an Independent Private Equity firm founded in 1982. Gilde Investment Management BV is headquartered in Utrecht.

Radiometer A/S develops as well as manufactures blood gas instruments and support devices. It supplies blood gas analyzers that measure blood gases and other parameters used to diagnose critically ill patients. It also provides accessories, IT systems and support services for blood gas testing, besides producing instruments that measure blood gases transcutaneously. The company consists of three subsidiaries Radiometer Medical ApS (Denmark), SenDx Medical, Inc. (US) and Radiometer Basel AG (Switzerland). Radiometer was founded in 1935 and is headquartered in Br?nsh?j, Denmark.

Cambridge Cognition Ltd. operates as a neuroscience technology company delivering near-patient assessment solutions to improve the understanding, diagnosis and treatment of neurological and psychiatric disorders. It offers CANTAB Tests and Services, CANTAB mobile and CANTABeclipse. The company was founded in 2002 and is headquartered in Cambridge, GB.

Part of Surgicraft Group Management, Surgicraft Group manufactures and distributes orthopaedic implants and obstetric monitoring devices. Surgicraft Group was acquired by Surgicraft Group Management on September 01, 1994.

Chroma Therapeutics Ltd. engages in the discovery and development of therapies for the treatment of cancer and inflammation. It focuses on the discovery and development of novel small molecule drugs based upon chromatin biology and novel cell accumulation approaches. The firm uses chromatin biology, drug accumulation approaches to discover and develop cancer, inflammation treatments and small molecule drugs. The company was founded by David Allis, Alan Hornsby Davidson, Alan Hastings Drummond, Anthony Kouzarides and Paul Workman in September 2001 and is headquartered in Abingdon, the United Kingdom.

Hybrid is an Oxford Biotechnology Company focused on revolutionizing viral vaccines with its patented vaccine delivery technologies. Hybrid has an established and well equipped laboratory located at Cherwell Innovation Centre in Oxford shire, which houses both its corporate research facility and contract research services. Using a mixed product and platform business model it is developing its in-house lead products towards phase I/II proof of concept clinical trials as well as furthering its partnerships with leading pharmaceutical and biotechnology companies. Hybrid's experienced scientific and management team has reached this late stage of development through a highly efficient use of grant funding and revenues, together with minimal seed funding. With its unparalleled expertise in the field of viral steal thing technologies, The firm is also able to offer general and bespoke virology services, including high-quality adenovirus production and purification. Hybrid BioSystems uses iLabber electronic lab books for maximum IP protection and secure data storage.

Mercia Fund Management Ltd. (Mercia Fund) is a private equity subsidiary of Mercia Asset Management Plc founded in 1999 by Mark Andrew Payton, Timothy R. Hazell and Everard Mascarenhas. The firm is headquartered in Warwickshire, Great Britain.

Gilde Healthcare Partners BV is a Private Equity/Venture Capital firm, a subsidiary of Gilde Healthcare Holding BV founded in 1999 by Pieter van der Meer and Edwin William de Graaf. Gilde Healthcare Partners BV is headquartered in Utrecht with additional office in Cambridge.

Part of Merck KGaA, Sigma-Aldrich Finance Co. is a company that wholesales chemicals and related products. The company is based in St. Louis, MO.

Acacia Pharma Ltd. develops supportive care product opportunities for post-surgical and cancer patients. It specializes in the discovery and development of cancer supportive care product opportunities based on established drugs. The firm’s product pipeline addresses supportive care indications, such as post-operative and chemotherapy-induced nausea and vomiting, xerostomia and cachexia. The company was founded by Andrew Muncey, Julian Clive Gilbert and Robert William Gristwood in 2006 and is headquartered in Cambridge, the United Kingdom.

Lab 21 Ltd. operates as a healthcare diagnostics company. It specializes in providing patients, doctors, hospitals ,and healthcare providers with diagnostic information for disease identification, disease predisposition, and personalized medicine, to help in managing health problems. It also offers diagnostic products and services and supports blood bank screening, medical diagnostics, and drug discovery. The company was founded in April 2005 by Berwyn E. Clarke and is headquartered in Cambridge, the United Kingdom.

Macrotarg Ltd. is a biotechnology research and British experimental development company founded in 2007. The private company is based in Winnersh, UK.

Akamis Bio Ltd. operates as a biotechnology company which develops novel therapeutics that addresses cancer and other clinically unmet diseases. Its products include Enadenotucirev, Espindolol and AbEnAd. The firm also develops treatments based upon the research phase vaccine platform PolySTAR, which combines recombinant viral vectors with polymers to shield them from the immune system, and the research phase adjuvant and immunotherapeutic platform PolyMAP, which combines polymers with synthetic adjuvants to significantly enhance the effectiveness of vaccines. The company was founded by Andrew Justin Stewart Coats and Stefan D. Anker on November 17, 2006 and is headquartered in Abingdon, the United Kingdom.

Oxford Genetics Ltd. produces modular DNA plasmids for biological research. Its products include DNA systems, kits, and cell lines. The company was founded by Ryan Cawood and Leonard Seymour on April 28, 2011 and is headquartered in Oxford, the United Kingdom.

Cisiv Ltd. develops technology solutions for pharmaceutical companies. It offers web-based software platform that allows patient data to be easily captured, analyzed, and shared. The company was founded in 1995 by Dominic Michael Trafford Farmer and Ruth Helen Whittaker and is headquartered in Kingston-upon-Thames, the United Kingdom.

Part of GSK Plc, GSK International Ltd. operates a travel agency. The company is based in Ilford, UK.

Eyoto Group Ltd. develops software that supports optometrists with diagnosis, selling optical products and conducting clinical trials. Its products include diagnosis support system, condition-specific diagnosis and management system, sales acceleration and clinical trials system, domiciliary solutions and consultancy services. The company was founded by Mark Dunne, Thomas Drew and James Wolffsohn in December 2013 and is headquartered in Birmingham, the United Kingdom.

Intelligent Health Ltd. provides combatting inactivity through behavioral science and technology. It serves primary care providers, community serves, schools, sports entities, and other businesses and individuals. The company was founded by William Bird in 2006 and is headquartered in Reading, the United Kingdom.

Foodient Ltd. operates an online recipe and shopping list platform. It offers smart shopping list tool such as Whisk Leftovers and WhiskAds. The Whisk Leftovers, is a leftover recipe search engine sources of online recipes. The WhiskAds, is an advertising platform that inserts intelligent native ads on recipes and shopping lists. The company was founded by Nick Holzherr in January 2013 and is headquartered in Birmingham, the United Kingdom.

eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium.

Macrophage Pharma Ltd. engages in research and experimental development on biotechnology. The company is headquartered in Berkhamsted, the United Kingdom.

Sense Biodetection Ltd. provides molecular diagnostics research services. It focuses on improving healthcare decisions and processes by developing novel, user-centred, handheld tests in the fields of infections and oncology. The company was founded by Harry John Lamble and Ralph Lamble in 2014 and is headquartered in Abingdon, the United Kingdom.

Bioarchitech Ltd. operates as a biotechnology company that develops oncolytic viruses for treatment of cancer. The company was founded by Kevin Maskell, Lili Wang, Geoffrey Hale, and Hannah Chen in 2014 and is headquartered in Bicester, the United Kingdom.

Absolute Antibody Ltd. provides antibody sequencing, manufacturing and engineering services. Its products include anti-allergen antibodies, anti-virus antibodies, multi-tag control protein and research grade biosimilars. The company was founded by Nicholas J. Hutchings and Neil Barclay in August 2012 and is headquartered in Oxford, the United Kingdom.

C7 Ventures Ltd. operates as a British investment company. The private company is based in Birmingham, UK.

Axis Spine Technologies Ltd. engages in experimental development on natural sciences and engineering. The company is headquartered in Hertfordshire, the United Kingdom.